Laurus Labs gets EIR from USFDA for unit 6 in Andhra Pradesh

04 Feb 2019 Evaluate

Laurus Labs has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its Unit 6 on February 2, 2019. The manufacturing unit 6 was inspected by the regulatory agency in the month of November 2018 and is located at APSEZ, Atchutapuram, Visakhapatnam in the state of Andhra Pradesh.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

586.80 5.35 (0.92%)
18-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1748.60
Dr. Reddys Lab 1164.70
Cipla 1508.70
Lupin 2035.30
Zydus Lifesciences 903.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...